Robert Lahasky, M.D.,
NPI 1922086339 · Family Medicine Physician · New Iberia, LA
Enrolled with Medicare as Practitioner - Family Practice · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1922086339
- Entity type
- Individual
- Primary specialty
- Family Medicine PhysicianAllopathic & Osteopathic Physicians
- Credential
- M.D.,
- Sex
- Male
- Sole proprietor
- Yes
- License
- 016849 (LA)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
20 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
983 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 | 499 | $83 |
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 185 | $117 |
| Hemoglobin A1c Level83036 | 112 | $10 |
| Administration of Influenza Virus VaccineG0008 | 88 | $30 |
| Injection of Drug Or Substance Under Skin Or Into Muscle96372 | 39 | $13 |
| Administration of Pneumococcal VaccineG0009 | 22 | $25 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 157 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Atorvastatin Calcium | 636 | 166 |
| Amlodipine Besylate | 554 | 145 |
| Metformin Hcl | 552 | 150 |
| Meloxicam | 413 | 128 |
| Lisinopril | 399 | 111 |
| Lisinopril/Hydrochlorothiazidebrand: Lisinopril-Hydrochlorothiazide | 293 | 77 |
| Levothyroxine Sodium |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$1,105 across 54 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2006-01-05
- Last updated
- 2011-05-03
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.